REED

#4757
Reed's, Inc. Common Stock
0.8 8 USD
+0.01%
Market Price
Settore: Beni di Consumo Difensivi
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.88
0.88
Intervallo Annuale
0.75
5.97
Variazione giornaliera
+1.15%
Variazione Mensile
-1.12%
Variazione di 6 mesi
-62.87%
Variazione Annuale
-72.67%
Chiusura Precedente
0.8 7
Open
0.8 8
Minimo
0.8 8
Massimo
0.8 8
Volume
1
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
REED's, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
REED's, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
REED's, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
REED's, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
REED's, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
REED's, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
REED's, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
REED's, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
REED's, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
REED's, INC. quarterly report, Q1 FY2026
10-Q

REED's, INC. current report, Q2 FY2020

Full document

Business Context and Reporting Period

Company: REED's, INC. (NASDAQ: REED)
Filing Type: Form 8-K (Current Report)
Date of Report: April 15, 2020 (Event Date: April 16, 2020)
Context: The filing reports the entry into a material definitive agreement for an underwritten public offering of common stock.

Key Financial Metrics and Transaction Details

This filing details a capital raise rather than operational financial results. Key transaction metrics include:

  • Shares Offered: 13,333,334 shares of common stock.
  • Offering Price: $0.375 per share.
  • Over-Allotment Option: Underwriter granted a 45-day option to purchase up to 2,000,000 additional shares.
  • Expected Gross Proceeds: Approximately $5.0 million (or $5.75 million if the over-allotment option is fully exercised).
  • Net Proceeds: Not specified; gross proceeds are before deducting underwriting discounts and offering expenses.
  • Expected Closing Date: On or about April 20, 2020.

Note: The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures.

Material Changes Versus Prior Period

The filing does not report operational changes or comparative financial performance versus prior periods. The material change is the execution of the Underwriting Agreement with Roth Capital Partners, LLC, representing a significant dilution event and capital injection.

Guidance, Outlook, and Risks

  • Management Commentary: The offering is being conducted pursuant to a shelf registration statement effective since February 8, 2019.
  • Conditions to Closing: The transaction is subject to the satisfaction of customary closing conditions.
  • Risks and Contingencies: The company has agreed to indemnify the underwriters against certain liabilities under the Securities Act of 1933. The final proceeds depend on the exercise of the over-allotment option and the deduction of offering expenses.

Investor Verification Checklist

  • Verify the final closing date and actual net proceeds after underwriting discounts.
  • Confirm whether the underwriter exercises the 2,000,000 share over-allotment option.
  • Review the final prospectus supplement for specific use of proceeds.
  • Assess the impact of the share issuance on existing shareholder dilution.